Product correctly added to cart.

discount label
24-Norursodeoxycholic acid
View 3D

Biosynth logo

24-Norursodeoxycholic acid

CAS: 99697-24-2

Ref. 3D-FN26417

50g
19,278.00 €
25mg
284.00 €
50mg
426.00 €
100mg
568.00 €
250mg
1,018.00 €
Estimated delivery in United States, on Monday 3 Feb 2025

Product Information

Name:
24-Norursodeoxycholic acid
Controlled Product
Synonyms:
  • (3a,5b,7b)-3,7-Dihydroxy-24-norcholan-23-oic acid3a,7b-Dihydroxy-24-nor-5b-cholan-23-oic acidNorursodeoxycholic acid
Description:

Norursodeoxycholic acid (UDCA) is a bile acid that is synthesized from cholesterol in the liver. It has been shown to have anti-inflammatory effects and is used as a treatment for bowel disease, particularly primary sclerosing cholangitis. UDCA has been shown to be beneficial for patients with metabolic disorders such as hepatic steatosis and metabolic syndrome. This drug also has pharmacokinetic properties that are independent of its function as an anti-inflammatory agent, which may be due to its ability to increase the glomerular filtration rate and improve lipid metabolism.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
378.55 g/mol
Formula:
C23H38O4
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FN26417 24-Norursodeoxycholic acid

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".